This event will cover two timely issues for those interested in intellectual property or pharmaceutical patents.
Recently, there was an important court decisions in England on second medical use patents. As Hong Kong is likely to follow suit, there has been a lot of discussion and debate on this topic. Andrew Cobden from Hogan Lovells, who has been practicing patent law for more than 25 years will help provide clarity on this topic.
A number of key policy challenges for innovative companies will need to be addressed in 2017. Perhaps no larger issue confronts multi-national companies in Asia more than what will come next now that the U.S. has withdrawn from the Trans-Pacific Partnership (TPP) trade agreement – and specifically, what will happen with the rules that were laid out and intensely negotiated in the IPR chapter?
First 15-20 minutes is for networking
Sandwiches and beverages included
This event is co-hosted by the Intellectual Property Committee
and Pharmaceutical Committee